Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression.

Expert review of molecular diagnostics - 1 Apr 2023

Nikolac Perkovic Matea, Gredicak Martin, Sagud Marina, Nedic Erjavec Gordana, Uzun Suzana, Pivac Nela

Abstract excerpt

INTRODUCTION: Recent evidence from the studies evaluating the association between brain-derived neurotrophic factor (BDNF) concentration/levels, BDNF Val66Met (rs6265) polymorphism, and major depressive disorders, referred as depression, and the association between BDNF levels and/or BDNF Val66Met with the treatment response in depression is presented. AREAS COVERED: This mini review focuses on the changes in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain-Derived Neurotrophic Factor

Share to Depression

Share to Depressive Disorder, Major

Share to Genotype

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 37038358
DOI: 10.1080/14737159.2023.2200937

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression.PMID 37038358Read ↗

Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy.Semantic proximity Read ↗

Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.Semantic proximity Read ↗

Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level.Semantic proximity Read ↗

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder.Semantic proximity Read ↗

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.Semantic proximity Read ↗

Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Schizophrenia and Bipolar Disorder: A Systematic Review.Semantic proximity Read ↗

Is it time to reassess the BDNF hypothesis of depression?Semantic proximity Read ↗

Val66Met polymorphism in the BDNF gene and antidepressant response in depression: an updated meta-analysis.Semantic proximity Read ↗

Brain-derived neurotrophic factor and mental disorders.Semantic proximity Read ↗

BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy.Semantic proximity Read ↗

Association between BDNF (Val66Met) Gene Polymorphism, Oxidative Stress Biomarkers and Physiological Alterations in Early and Late Onset Geriatric DepressionSemantic proximity Read ↗

The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.